Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
CS Disco Q1 2026 Earnings Call - AI Platform Launch Drives Revenue Beat and Margin Expansion
CS Disco delivered a strong Q1 2026, beating revenue and adjusted EBITDA guidance as the launch of the all-in-one DISCO Platform and deepening AI adoption accelerated growth. Total revenue rose 14% ye...
- Total revenue grew 14% year-over-year to $41.9 million, beating the high end of guidance.
- Software revenue increased 12% to $34.7 million, marking the fourth consecutive quarter of accelerating growth.
- Adjusted EBITDA improved 600 basis points to a negative $3.5 million, outperforming the high end of guidance.
- +7 more takeaways
Acushnet Company Q1 2026 Earnings Call - Accelerated GTS Driver Launch and Tariff Uncertainty Offset by Strong Equipment Growth
Acushnet delivered a solid first quarter, with net sales rising 5% constant currency to $753 million and adjusted EBITDA up 4% to $145 million. The results were driven by strong momentum in Titleist g...
- Worldwide net sales increased 5% on a constant currency basis to $753 million in Q1 2026.
- Adjusted EBITDA rose 4% year-over-year to $145 million, up $6 million from Q1 2025.
- Titleist golf equipment sales grew 7%, supported by strong demand for balls and clubs.
- +7 more takeaways
Royalty Pharma Q1 2026 Earnings Call - Double-Digit Growth and R&D Co-Funding Surge
Royalty Pharma delivered a robust first quarter, growing portfolio receipts by 10% and recurring royalty receipts by 13%, driven by a diversified portfolio and strong clinical catalysts. Management ra...
- Royalty Pharma reported 10% growth in portfolio receipts and 13% growth in recurring royalty receipts for Q1 2026, demonstrating the resilience of its diversified portfolio.
- Management raised full-year 2026 guidance for portfolio receipts to $3.325 billion–$3.45 billion, up from the previous range of $3.275 billion–$3.425 billion.
- The company announced $1.25 billion in new transactions, including a $250 million upfront investment for a royalty on Ziihera, a HER2-targeted cancer therapy with blockbuster potential in gastric cancer.
- +9 more takeaways
SolarEdge Q1 2026 Earnings Call - Transitioning to Offensive Growth with Near-Break-Even Results and Strategic Shifts
SolarEdge delivered a pivotal Q1 2026 report that underscores a decisive shift from defensive cost-cutting to offensive growth, marked by 46% year-over-year revenue expansion and a clear path to near-...
- Q1 revenue surged 46% year-over-year to $310 million, marking the fifth consecutive quarter of growth without significant revenue pull-forward.
- Management guided for Q2 revenue between $325-$355 million, with a midpoint EBIT loss of approximately $3.5 million, signaling a near-break-even milestone.
- Non-GAAP gross margin expanded slightly to 23.5%, driven by a favorable product mix and lower seasonal warranty costs, while operating expenses came in well below guidance.
- +7 more takeaways
CVG Q1 2026 Earnings Call - Electrical Systems Momentum Offsets Class 8 Weakness
CVG delivered a mixed first quarter, with revenue growth and margin expansion in its Global Electrical Systems and Global Seating segments partially offset by a sharp pullback in Trim Systems. The com...
- Revenue reached $171.5 million, up slightly from $169.8 million in Q1 2025, driven by strength in Global Electrical Systems and Global Seating.
- Global Electrical Systems revenue surged 14% year-over-year to $57.4 million, fueled by new business wins and the production ramp for the Zoox autonomous vehicle program.
- Global Seating revenue grew 1.5% to $74.5 million, supported by higher international volumes and a 20% increase in aftermarket orders.
- +7 more takeaways
Madrigal Pharmaceuticals Q1 2026 Earnings Call - Rezdiffra Hits $1.1B Run Rate as MASH Market Expands 50%
Madrigal Pharmaceuticals delivered a commanding first quarter, with Rezdiffra net sales surging 127% year-over-year to $311 million and trailing twelve-month revenue crossing the $1.1 billion mark. Th...
- 1. Rezdiffra net sales surged 127% year-over-year to $311 million in Q1 2026, with trailing twelve-month revenue exceeding $1.1 billion, confirming blockbuster status.
- 2. The U.S. addressable MASH market grew nearly 50% in two years, expanding from 315,000 to 460,000 diagnosed patients, driven by increased awareness and specialist involvement.
- 3. Active patients on Rezdiffra more than doubled year-over-year, reaching over 42,250, with management noting strong momentum carrying into Q2 2026.
- +7 more takeaways
Ternium Q1 2026 Earnings Call - Mexican Steel Demand Recovery and USMCA Uncertainty
Ternium reported a 21% sequential increase in adjusted EBITDA for Q1 2026, driven by margin improvements and favorable foreign exchange movements, despite rising raw material costs. The company is nav...
- Adjusted EBITDA rose 21% sequentially in Q1 2026, reflecting margin expansion and foreign exchange gains, though raw material and logistics costs are rising.
- Mexican steel demand is expected to recover in Q2 2026, supported by government policies prioritizing domestic steel in public procurement and a shift from destocking to normalization.
- The Pesquería project in Mexico is ramping up ahead of schedule, with the cold rolling mill and galvanizing line expected to reach full capacity by October, enhancing vertical integration.
- +9 more takeaways
Chemours {Q1} {2026} Earnings Call - Quota Discipline and Pricing Power Drive Record TSS EBITDA Amid APM Recovery
Chemours delivered a first quarter that defied expectations, powered by record performance in its Thermal & Specialized Solutions (TSS) segment and disciplined pricing execution across Titanium Techno...
- TSS delivered a record first quarter with net sales up 22% year-over-year, driven by higher pricing, stronger volume growth, and favorable product mix in Freon and Opteon refrigerants.
- TT adjusted EBITDA exceeded expectations despite lower global volumes, thanks to disciplined global pricing execution and strong cost management, with a new long-term chlorine supply contract signed with Olin for the DeLisle site.
- APM reported a $25 million adjusted EBITDA headwind due to the Washington Works outage and prior Capstone line closure, but order velocity in high-value semiconductor and data center markets has reached multi-year highs.
- +7 more takeaways
Bloomin' Brands Q1 2026 Earnings Call - Guest Scores Climb as Turnaround Strategy Takes Hold
Bloomin' Brands reported a solid Q1 2026, with U.S. comparable restaurant sales rising 90 basis points despite a 180 basis point traffic decline heavily impacted by severe winter weather. The company’...
- U.S. comparable restaurant sales rose 90 basis points in Q1 2026, driven by a 270 basis point increase in average check, despite a 180 basis point traffic decline heavily offset by 240 basis points of severe winter weather impact.
- Outback Steakhouse’s guest metric scores improved for the third consecutive quarter, with brand trust up 4 points and significant gains in service, value, atmosphere, food quality, and intent to return.
- Management is executing a four-platform turnaround strategy focused on remarkable dine-in experience, brand relevancy, culture of ownership, and restaurant investment, with a new service model reducing server stations from six to four tables launching in April.
- +7 more takeaways
Uber Q1 2026 Earnings Call - Insurance Savings Fuel Mobility Acceleration and Profitable Expansion
Uber reported a strong start to 2026, with gross bookings up 21% year-over-year and non-GAAP EPS surging 44%. The company delivered top-line and profitability at or above the high end of guidance, dri...
- Gross bookings grew 21% year-over-year, with mobility accelerating to 20% growth and record margins, while delivery expanded 23% driven by grocery and retail.
- Non-GAAP EPS increased 44% year-over-year, more than twice the pace of bookings growth, reflecting significant operating leverage and disciplined cost management.
- Insurance cost savings in U.S. mobility markets, particularly Los Angeles and San Francisco, are materializing, leading to lower consumer prices, increased trip elasticity, and accelerating growth.
- +9 more takeaways